iSpecimen Inc (ISPC) Stock Analysis

iSpecimen Inc (ISPC) is a publicly traded company in the HEALTHCARE sector. It trades at $3.07, carries a market capitalization of $4.54M. This page summarizes the public market data, fundamentals, and frequently asked questions for ISPC, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

Market Sentiment

iSpecimen Inc currently has a Bearish sentiment score of -0.36.

About iSpecimen Inc

iSpecimen Inc. is a pioneering technology company headquartered in Lexington, Massachusetts, that revolutionizes the procurement of human biospecimens for life science research. By connecting researchers with a vast network of healthcare providers, iSpecimen specializes in sourcing essential biofluids, tissues, and living cells, meeting the increasing demand for high-quality specimens in the biomedical sector. Its innovative platform streamlines the biospecimen acquisition process, thereby ex...

GNG Research Analysis

GNG Research scores iSpecimen Inc (ISPC) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ISPC.

Frequently Asked Questions

Does ISPC pay dividends?

iSpecimen Inc (ISPC) does not currently pay a regular dividend.

What is ISPC's market cap?

iSpecimen Inc (ISPC) has a market capitalization of $4.54M with a current stock price of $3.07.